| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Over the last 12 months, insiders at Aethlon Medical, Inc. have bought $0 and sold $0 worth of Aethlon Medical, Inc. stock.
On average, over the past 5 years, insiders at Aethlon Medical, Inc. have bought $0 and sold $56,580 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2020-12-17 | Sale | Shah Chetan | director | 26,852 0.2008% | $2.11 | $56,580 | +15.02% | |
| 2010-04-13 | Sale | BROENNIMAN EDWARD G | director | 9,800 0.015% | $0.34 | $3,283 | -26.47% | |
| 2010-04-12 | Sale | BROENNIMAN EDWARD G | director | 25,000 0.0383% | $0.34 | $8,375 | -26.47% | |
| 2010-04-09 | Sale | BROENNIMAN EDWARD G | director | 25,000 0.0381% | $0.33 | $8,338 | -26.47% | |
| 2010-04-08 | Sale | BROENNIMAN EDWARD G | director | 25,000 0.0383% | $0.34 | $8,375 | -26.47% | |
| 2010-04-07 | Sale | BROENNIMAN EDWARD G | director | 24,000 0.0395% | $0.35 | $8,400 | -24.24% | |
| 2010-04-07 | Sale | BARRY FRANKLYN S JR | director | 8,800 0.0145% | $0.35 | $3,080 | -24.24% | |
| 2010-04-06 | Sale | BROENNIMAN EDWARD G | director | 23,800 0.0359% | $0.35 | $8,330 | -30.56% | |
| 2010-04-06 | Sale | BARRY FRANKLYN S JR | director | 23,800 0.0359% | $0.35 | $8,330 | -30.56% | |
| 2010-04-05 | Sale | BROENNIMAN EDWARD G | director | 23,000 0.0348% | $0.35 | $8,073 | -30.56% | |
| 2010-04-05 | Sale | BARRY FRANKLYN S JR | director | 23,000 0.0348% | $0.35 | $8,073 | -30.56% | |
| 2010-04-01 | Sale | BROENNIMAN EDWARD G | director | 22,800 0.0354% | $0.37 | $8,436 | -32.43% | |
| 2010-04-01 | Sale | BARRY FRANKLYN S JR | director | 22,800 0.0354% | $0.37 | $8,436 | -32.43% | |
| 2010-03-31 | Sale | BROENNIMAN EDWARD G | director | 22,000 0.0328% | $0.36 | $8,030 | -34.21% | |
| 2010-03-31 | Sale | BARRY FRANKLYN S JR | director | 22,000 0.033% | $0.37 | $8,074 | -34.21% | |
| 2010-03-30 | Sale | BROENNIMAN EDWARD G | director | 22,000 0.041% | $0.38 | $8,360 | -30.56% | |
| 2010-03-30 | Sale | BARRY FRANKLYN S JR | director | 22,000 0.0404% | $0.37 | $8,239 | -30.56% | |
| 2010-03-29 | Sale | BROENNIMAN EDWARD G | director | 22,000 0.0384% | $0.39 | $8,470 | -35.90% | |
| 2010-03-29 | Sale | BARRY FRANKLYN S JR | director | 22,000 0.0377% | $0.38 | $8,327 | -35.90% | |
| 2010-03-26 | Sale | BROENNIMAN EDWARD G | director | 20,000 0.0362% | $0.41 | $8,200 | -37.50% |
| Increased Positions | 10 | +40% | 267,548 | +133.19% |
| Decreased Positions | 8 | -32% | 45,501 | -22.65% |
| New Positions | 5 | New | 188,110 | New |
| Sold Out Positions | 4 | Sold Out | 12,350 | Sold Out |
| Total Postitions | 27 | +8% | 422,927 | +110.54% |
| Ikarian Capital, Llc | $300.00 | 4.69% | 750,000 | +750,000 | New | 2024-12-31 |
| Ubs Group Ag | $100.00 | 1.56% | 249,535 | +31,282 | +14.33% | 2024-12-31 |
| Boothbay Fund Management, Llc | $87.00 | 1.35% | 216,600 | +216,600 | New | 2024-12-31 |
| Geode Capital Management, Llc | $44.00 | 0.69% | 110,333 | +11,939 | +12.13% | 2024-12-31 |
| Virtu Financial Llc | $38.00 | 0.59% | 94,173 | +94,173 | New | 2024-12-31 |
| Sassicaia Capital Advisers Llc | $14.00 | 0.23% | 36,000 | +36,000 | New | 2024-12-31 |
| Allegiance Financial Group Advisory Services Llc | $12.00 | 0.19% | 30,000 | +30,000 | New | 2024-12-31 |
| Renaissance Technologies Llc | $12.00 | 0.18% | 29,307 | +29,307 | New | 2024-12-31 |
| Scientech Research Llc | $9.00 | 0.14% | 22,594 | +22,594 | New | 2024-12-31 |
| Two Sigma Investments, Lp | $9.00 | 0.14% | 22,556 | +7,120 | +46.13% | 2024-12-31 |